<DOC>
	<DOCNO>NCT01794780</DOCNO>
	<brief_summary>This multi-center study design describe natural history disease , treatment health care product physician-diagnosed COPD patient require add daily maintenance therapy real world .</brief_summary>
	<brief_title>A 1-year Multi-center , Prospective , Cohort Study Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Willing able provide inform consent Physiciandiagnosis COPD COPD patient require longacting bronchodilator treatment Patients spirometry available baseline Patients diagnosis asthma . Patients hospitalize COPD exacerbation 4 week prior Visit 1 . Current clinical diagnosis chronic respiratory illness Concurrent participation clinical trial use investigational drug . Active malignancy history malignancy organ system Pregnant nursing ( lactate ) woman Women childbearing potential contraception Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>